about
Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stagesActivation of rho GTPases by cytotoxic necrotizing factor 1 induces macropinocytosis and scavenging activity in epithelial cellsCNF1 improves astrocytic ability to support neuronal growth and differentiation in vitro.Rho-activating Escherichia coli cytotoxic necrotizing factor 1: macropinocytosis of apoptotic bodies in human epithelial cells.Hijacking Rho GTPases by protein toxins and apoptosis: molecular strategies of pathogenic bacteria.The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma modelEnhancement of learning and memory after activation of cerebral Rho GTPasesFunctional Analyses of the Crohn's Disease Risk Gene LACC1The Rho-activating CNF1 toxin from pathogenic E. coli: a risk factor for human cancer development?Bacterial protein toxins: current and potential clinical use.The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators.The E. coli CNF1 as a pioneering therapy for the central nervous system diseases.Bacterial protein toxins in human cancers.Electrophysiology of glioma: a Rho GTPase-activating protein reduces tumor growth and spares neuron structure and function.Cell-to-cell propagation of the bacterial toxin CNF1 via extracellular vesicles: potential impact on the therapeutic use of the toxin.Enhancement of mitochondrial ATP production by the Escherichia coli cytotoxic necrotizing factor 1.The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors.Clostridium difficile toxin B causes apoptosis in epithelial cells by thrilling mitochondria. Involvement of ATP-sensitive mitochondrial potassium channels.A multinucleating Escherichia coli cytotoxin perturbs cell cycle in cultured epithelial cells.Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases.The Rac-activating toxin cytotoxic necrotizing factor 1 oversees NK cell-mediated activity by regulating the actin/microtubule interplay.The 5' region of cnf1 harbours a translational regulatory mechanism for CNF1 synthesis and encodes the cell-binding domain of the toxin.Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome.Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex.Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.High yield purification and first structural characterization of the full-length bacterial toxin CNF1.Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.Epithelial cells challenged with a Rac-activating E. coli cytotoxin acquire features of professional phagocytes.Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer.The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.Multinucleation and pro-inflammatory cytokine release promoted by fibrous fluoro-edenite in lung epithelial A549 cellsN -Acetylcysteine protects epithelial cells against the oxidative imbalance due to Clostridium difficile toxinsHinderance of Apoptosis and Phagocytic Behaviour Induced byEscherichia coliCytotoxic Necrotizing Factor 1: Two Related Activities in Epithelial CellsThe Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot StudyThe Escherichia coli protein toxin cytotoxic necrotizing factor 1 induces epithelial mesenchymal transitionExtracts from Cell Suspension Cultures of Strawberry (Fragaria x ananassa Duch): Cytotoxic Effects on Human Cancer CellsEye Drop Instillation of the Rac1 Modulator CNF1 Attenuates Retinal Gliosis and Ameliorates Visual Performance in a Rat Model of Hypertensive RetinopathyCnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma
P50
Q33618760-84551781-5102-4662-A27F-E4CBDE50F108Q33937553-C02B8E32-E5EF-4B0E-8ECB-9DE4AE63F946Q34241648-9643EBE2-52D5-456E-BB1B-03298EAB175CQ34560442-30D58CDB-0537-48FB-93C3-E807C48A6569Q35109696-37B7DDBD-F16A-48BA-B169-E7442F2A7DDCQ35189981-4BA2605B-BE07-4114-951E-674EC3498201Q35568605-2589E965-E070-44B3-A8D6-274A9862D75DQ36222331-6FEFAC30-0D2B-493E-9E3B-BD13A1ED2886Q37108929-E8ADAB02-7297-4380-ADAC-076A4F9D3CB1Q37160800-8911DED1-04FC-4272-A480-1F62BBFFCBB6Q38129243-7F63179E-3C70-4AEA-821C-56C01BA07A63Q38176761-9D603317-3643-4A80-933D-B779DB65BFA2Q38624717-C033085D-EC4B-4088-8AB9-132F01C5E458Q38764612-F790BB27-A14E-4C66-97A7-46C3BFC74A36Q38820362-889BDCBE-9498-428D-A9C7-D62ECF32A968Q38985318-6B210C09-F253-45ED-BEE5-4352348043C7Q39824582-1CC5930D-33D4-435D-8CAF-4047E4414E76Q40183668-238C02EC-8DE4-4797-9B81-86F9651E23A9Q40215866-45FCBFA0-1636-4981-BAEA-F5BD1781B1F3Q40498408-AC082E12-24B5-4388-8BC2-085EF5265B78Q40557652-9E7BA86C-E7B2-4B29-B1F2-3732B9E75170Q40941107-AE9E3E42-DC9A-4B73-B631-C7E2FCE884CFQ42057101-01BB555E-E022-4612-8E87-00340F847EECQ42132669-5DE62620-38DD-48B1-A058-7EF64492E9B3Q42621359-B5A3B9E3-AAEF-472C-A8BA-480C5EC7A96BQ46768571-36FB576E-78D7-4C35-A454-0E1A250F2DBAQ47235786-00E5A33C-082F-4CEC-80F0-B0EC8E49B59EQ48221956-88F2C39D-429F-4D14-A888-2EE2CC39084AQ51747980-6DB859A3-E64C-464F-81CE-60F1CC4713F2Q54542318-C6C0371D-C6C5-4D84-AAEF-739E27700FBAQ54956421-D7C298A9-5B1E-4AB1-9526-12B5E06F3853Q55104126-5C1D7D5D-D635-4BCC-A928-AC1FDA703EB4Q60324067-9608F44C-8327-4D8C-8588-0CFEF7A025C1Q60687752-2058549D-B3BC-44E8-B676-793E9A3BD11CQ60687763-199D1673-172B-4984-B675-9F84C5D171BFQ60716474-8D90CFF0-07B5-483C-8E11-0BBED7CA02C1Q91167645-CD17027D-C7D3-4822-ADE8-41771144E0E9Q91795578-0CD4DE3A-0EDF-401F-8F67-55BCB4112A15Q92288406-E33273AF-821C-4CF5-96A1-60B12C949E90Q94583206-F924ABB7-85A3-44F6-B6BF-14F4020DBFF2
P50
description
researcher
@en
name
Alessia Fabbri
@en
Fabbri A
@nl
type
label
Alessia Fabbri
@en
Fabbri A
@nl
altLabel
Fabbri A
@en
prefLabel
Alessia Fabbri
@en
Fabbri A
@nl
P106
P31
P496
0000-0002-3075-3367